Outlook Therapeutics, Inc. (OTLK) Ownership

NASDAQ: OTLKTop holders, insider trades and short interest.

OTLK ownership summary

as of October 17, 2026
Institutions
25.4%
of shares outstanding
Insiders
12.64%
of shares outstanding
Shares outstanding
243.4M
Float
176.6M
shares available to trade
Short interest
13.88%
31.9M shares short
Days to cover
7.10
short interest down 1.0% vs prior month
  • Institutions 25.44%
  • Insiders 12.64%
  • Other investors 61.92%

OTLK top institutional holders

20 largest
Outlook Therapeutics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Vanguard Capital Management, LLC1.80%4.4M$2.1M+2.4M (+122.5%)June 30, 2026
2Perceptive Advisors LLC1.29%3.1M$1.5M+3.1M (0.0%)June 30, 2026
3Marshall Wace Asset Management Ltd0.82%2.0M$969,938+2.0M (0.0%)June 30, 2026
4BlackRock Inc0.69%1.7M$814,267+1.2M (+249.5%)June 30, 2026
5Jane Street Group LLC0.59%1.4M$695,532+1.4M (0.0%)June 30, 2026
6Geode Capital Management, LLC0.51%1.2M$607,984+642,262 (+106.4%)June 30, 2026
7Susquehanna International Group, LLP0.40%968K$472,477+834,106 (+622.1%)June 30, 2026
8HRT FINANCIAL LLC0.32%785K$383,033+717,145 (+1,058.4%)June 30, 2026
9Vanguard Fiduciary Trust Co0.27%662K$322,892+485,135 (+274.8%)June 30, 2026
10GILPIN WEALTH MANAGEMENT, LLC0.23%555K$270,840−45,162 (−7.5%)June 30, 2026
11State Street Corp0.22%540K$263,423+376,700 (+231.0%)June 30, 2026
12CANTOR FITZGERALD, L. P.0.18%450K$219,600+450,000 (0.0%)June 30, 2026
13Sanctuary Advisors, LLC0.14%345K$168,130+344,529 (0.0%)June 30, 2026
14Group One Trading, LLC0.10%246K$120,257+132,727 (+116.7%)June 30, 2026
15Northern Trust Corp0.10%238K$115,930+170,171 (+252.5%)June 30, 2026
16SIMPLEX TRADING, LLC0.08%205K$100,046+72,347 (+54.5%)June 30, 2026
17LPL Financial Corp0.08%185K$90,252+151,315 (+450.0%)June 30, 2026
18UBS Group AG0.06%152K$74,281+19,146 (+14.4%)June 30, 2026
19Deutsche Bank AG0.05%131K$63,782+130,700 (0.0%)June 30, 2026
20Wealth Management Partners, LLC0.05%118K$57,667+118,170 (0.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 19 holders added 14.8M shares and 1 cut 45K.

OTLK top mutual fund and ETF holders

10 largest
Outlook Therapeutics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Albion Enterprise VCT Ord3.84%9.3M$4.6M+9.3M (0.0%)March 31, 2026
2Vanguard MStar Total Stk Mkt Idx Invest2.85%6.9M$3.4M+3.9M (+125.9%)August 31, 2026
3Fidelity Extended Market Index0.22%539K$262,954+9,673 (+1.8%)August 31, 2026
4Fidelity Total Market Index0.08%197K$96,166—August 31, 2026
5Fidelity Series Total Market Index0.07%160K$77,875—August 31, 2026
6Vanguard Balanced Index Inv0.05%116K$56,847+86,869 (+293.3%)August 31, 2026
7Vanguard MStar Inst Ttl StkMktIdxInstlPl0.02%46K$22,500—August 31, 2026
8Vanguard U.S. Eq Idx £ Acc0.02%41K$20,075—August 31, 2026
9JHVIT Total Stock Market Index I<0.01%2,556$1,247+2,556 (0.0%)August 31, 2026
10Knights of Columbus U.S. All Cap Idx I<0.01%603$294—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

OTLK insider transactions

latest 2
Outlook Therapeutics, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-09-26Lawrence A KenyonBuy$5.695,000$28,450
2024-03-28Yezan Munther HaddadinBuy$11.821,882$22,245

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

OTLK shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns OTLK

Institutional investors own 25.4% of Outlook Therapeutics's shares and insiders 12.64%. The largest holder is Vanguard Capital Management, LLC with 1.80% of the shares (4.4M), as of June 30, 2026. Among the top 20 institutions, 19 added shares and 1 reduced their stake in the latest filings. Short interest is 13.88% of the float, or 7.10 days of average trading volume. The share count rose 27,031.4% since 2014.

Related: OTLK analyst forecast, OTLK key metrics. See the OTLK stock overview for the latest quote and news.

OTLK ownership FAQ

Who owns the most Outlook Therapeutics stock?

The largest shareholders of Outlook Therapeutics are Vanguard Capital Management, LLC (1.80%), Perceptive Advisors LLC (1.29%), Marshall Wace Asset Management Ltd (0.82%), BlackRock Inc (0.69%), Jane Street Group LLC (0.59%).

What percentage of Outlook Therapeutics is owned by institutions?

Institutions hold 25.4% of Outlook Therapeutics's shares outstanding; insiders hold 12.64%.

Which funds own Outlook Therapeutics?

The largest fund holders of Outlook Therapeutics are Albion Enterprise VCT Ord (3.84%), Vanguard MStar Total Stk Mkt Idx Invest (2.85%), Fidelity Extended Market Index (0.22%), Fidelity Total Market Index (0.08%), Fidelity Series Total Market Index (0.07%).

What is Outlook Therapeutics's short interest?

31.9M shares of Outlook Therapeutics were sold short, 13.88% of the float; at the average daily volume it would take 7.10 days to cover.

Are insiders buying or selling Outlook Therapeutics?

Of the latest 2 reported insider transactions in Outlook Therapeutics (since March 28, 2024), 2 were purchases and 0 were sales.

How many shares of Outlook Therapeutics are outstanding?

Outlook Therapeutics has 243.4M shares outstanding, of which 176.6M are in the public float.

Biotechnology: ownership